Collagen Cross-linking in Keratoconus
Recruiting
N/A
Interventional Study
Keratoconus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Oregon Health and Science University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Optical Coherence Tomography (OCT) devices are non-contact instruments that can measure the depth of scars, other causes of cloudiness of the cornea, and degree of corneal thinning in patients with keratoconus. Laser Custom Corneal Collagen Cross-linking (CXL) significantly decreases corneal aberrations and improves vision. This study will use OCT-guided setting for the lasers used in the corneal …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of keratoconus
* Minimum corneal thickness of 410 microns
Exclusion Criteria:
* Inability to maintain fixation for OCT imaging
* Inability to commit to required study visits
* Inability to give informed consent
* Eyes with concurrent retinal diseases, glaucoma, or …
Contacts